Peters, K., Lipp, E., Broadwater, G., Herndon, J. I. I., Johnson, M., Randazzo, D., … Affronti, M. (2020). CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. In NEURO-ONCOLOGY (Vol. 22, pp. 137–137).

Peters, Katherine, Eric Lipp, Gloria Broadwater, James I. I. Herndon, Margaret Johnson, Dina Randazzo, Annick Desjardins, Henry Friedman, David Ashley, and Mary Affronti. “CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS.” In NEURO-ONCOLOGY, 22:137–137, 2020.

Peters K, Lipp E, Broadwater G, Herndon JII, Johnson M, Randazzo D, et al. CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. In: NEURO-ONCOLOGY. 2020. p. 137–137.

Peters, Katherine, et al. “CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 137–137.

Peters K, Lipp E, Broadwater G, Herndon JII, Johnson M, Randazzo D, Desjardins A, Friedman H, Ashley D, Affronti M. CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. NEURO-ONCOLOGY. 2020. p. 137–137.